Clinical Trial: A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
Study Status: Completed
Recruit Status: RECRUITING
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Safety, Tolerability and Pharmacokinetic Study of Tirzepatide for the Treatment of Pediatric Participants (6 Years to 11 Years) With Obesity
Brief Summary:
The main purpose of this study is to evaluate the safety and tolerability of tirzepatide (LY3298176) in pediatric participants with obesity.The blood tests will be performed to investigate how the body processes the study drug in these participants.For each participant, the study will last about approximately 13 weeks excluding the screening period.
Read more